Manasson, J., Wallach, D. S., Guggino, G., Stapylton, M., Badri, M. H., Solomon, G., Reddy, S. M., Coras, R., Aksenov, A. A., Jones, D. R., Girija, P. V., Neimann, A. L., Heguy, A., Segal, L. N., Dorrestein, P. C., Bonneau, R., Guma, M., Ciccia, F., Ubeda, C., Clemente, J. C., & Scher, J. U. (2020). interleukin‐17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin‐25–Driven Intestinal Inflammation. Arthritis & rheumatology, 72(4), 645–657. http://access.bl.uk/ark:/81055/vdc_100103148688.0x000008